🇬🇧 ENJAYMO in United Kingdom

ENJAYMO (SUTIMLIMAB-JOME) regulatory status in United Kingdom.

Marketing authorisation

MHRA

  • Status: likely_approved

ENJAYMO in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Immunology approved in United Kingdom

Frequently asked questions

Is ENJAYMO approved in United Kingdom?

Yes. MHRA has authorised it.

Who is the marketing authorisation holder for ENJAYMO in United Kingdom?

RECORDATI RARE DISEASES, INC. is the originator. The local marketing authorisation holder may differ — check the official source linked above.